Investors

2024 full year and fourth quarter announcement

We announced our full year and fourth quarter 2024 results on Wednesday 5 February. Access our full year and fourth quarter results and latest Annual Report below.

We’re confident in our future

With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.

Speeches and presentations

David Redfern

Goldman Sachs Biopharma Innovation Summit

27 March 2025

David Redfern, President, Corporate Development, attended the Goldman Sachs Biopharma Innovation Summit in London on Thursday, 27 March 2025.

Julie Brown sat on a grey sofa smiling

BNP Paribas Exane Healthcare Conference

25 March 2025

Julie Brown, Chief Financial Officer, participated in a virtual fireside chat at the BNP Paribas Exane Healthcare Conference on Tuesday, 25 March 2025.

Luke Miels

TD Cowen 45th Annual Health Care Conference

03 March 2025

Luke Miels, Chief Commercial Officer, participated in a fireside chat at the TD Cowen 45th Annual Health Care Conference in Boston on Monday, 3 March 2025.

Emma Walmsley

43rd Annual J.P. Morgan Healthcare Conference

Listen to the webcast
14 January 2025

Emma Walmsley, Chief Executive Officer, presented at the 43rd annual JP Morgan Healthcare Conference on Tuesday 14 January. The 40 minute session included a presentation and a moderated Q&A discussion.

DNA And Tech Science Image

Meet the management: Early pipeline

Watch the recording
17 December 2024

On 17 December, GSK management held a virtual event, "Early pipeline", featuring a presentation and an interactive Q&A session.

GSK share price

Share price tool

Detailed information on GSK's share price, including an interactive chart

Go to share price tool
two scientists talking

Get in touch with our investor team